Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $19.60 and last traded at $19.60, with a volume of 4227480 shares. The stock had previously closed at $13.42. Wall Street Analysts Forecast Growth Several research firms have issued […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) CEO Troy Edward Wilson sold 91,052 shares of Kura Oncology stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $20.23, for a total value of $1,841,981.96. Following the sale, the chief executive officer now directly owns 559 shares of […]
Insider Selling: Kura Oncology, Inc. (NASDAQ:KURA) CEO Sells 91,052 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Research analysts at Zacks Research decreased their Q2 2024 earnings per share estimates for shares of Puma Biotechnology in a research report issued on Thursday, August 17th. Zacks Research analyst K. Shah now expects that the biopharmaceutical company will earn $0.06 per share for the quarter, down […]
StockNews.com started coverage on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on PBYI. HC Wainwright reiterated a buy rating and set a $8.00 price objective on shares of […]